Does cephalexin cover Enterococcus faecalis in a male urinary tract infection?

No, cephalexin does NOT cover Enterococcus faecalis and should not be used for this infection in males.

Cephalexin is explicitly ineffective against Enterococcus faecalis—the FDA drug label clearly states that "most strains of enterococci (Enterococcus faecalis) are resistant to cephalosporins, including cephalexin" 1. This is intrinsic resistance, meaning E. faecalis is inherently not susceptible to first-generation cephalosporins regardless of susceptibility testing.

Why This Matters for Male UTIs

UTIs in males are automatically classified as complicated UTIs because they occur in anatomically abnormal urinary tracts (prostatitis cannot be excluded) 2. The 2024 European Association of Urology guidelines note that Enterococcus species are among the most common pathogens in complicated UTIs 2, making appropriate antibiotic selection critical for morbidity and mortality outcomes.

What You Should Use Instead

For E. faecalis UTI in males, the evidence-based options are:

First-Line Treatment

• Amoxicillin is the preferred agent 3
  • Dose: 80-100 mg/kg/day (typically 1-2g every 6-8 hours)
  • Duration: 14 days for males (to cover potential prostatitis) 2, 3
  • 86% of French infectious disease specialists choose this as first-line 3

Alternative Options (if penicillin allergy)

• Linezolid: Preferred alternative (51% of specialists) 3

  • Proven efficacy with 97.5% success rate in enterococcal UTI 4
  • Duration: 14 days 3

• Fluoroquinolones (levofloxacin): Second alternative (38% of specialists) 3

  • Only if local resistance <10% and patient hasn't used fluoroquinolones in last 6 months 2
  • More controversial—37% of specialists consider inappropriate 3

For Severe/Complicated Cases

The EAU guidelines recommend combination therapy for complicated UTIs with systemic symptoms 2:

• Amoxicillin plus aminoglycoside, OR
• Second-generation cephalosporin plus aminoglycoside

Critical Clinical Pitfalls

1. Don't assume all cephalosporins work the same: While second and third-generation cephalosporins may have some activity when combined with aminoglycosides for complicated UTI 2, first-generation agents like cephalexin have NO activity against enterococci 1

2. Always obtain culture and susceptibility testing in male UTIs before finalizing therapy 2

3. Consider therapeutic abstention in specific scenarios 3:

   • Catheterized patients (51% would not treat)
   • Polymicrobial cultures (50% would not treat)
   • Leukocyturia <10⁴/mL (64% would not treat)

4. Duration matters: The 14-day duration for males is non-negotiable because prostatitis cannot be excluded 2, 3

The molecular basis for this resistance involves intrinsic cephalosporin resistance mechanisms in enterococci 5, making this a predictable treatment failure rather than acquired resistance.